当前位置:首页 - 行情中心 - 中国医药(600056) - 财务分析

中国医药

(600056)

  

流通市值:137.72亿  总市值:137.77亿
流通股本:14.95亿   总股本:14.96亿

中国医药(600056)财务分析

净利润 + 每股收益
------
  • 净利润(亿元)
  • 每股收益(元)

    截至2026年第一季度实现净利润2.37亿元,每股收益0.12元。

股东权益 + 未分配利润
------
  • 股东权益(亿元)
  • 未分配利润(亿元)

    截至2026年第一季度最新股东权益1460078.04万元,未分配利润826374.42万元。

总资产 + 负债
------
  • 总资产(亿元)
  • 负债(亿元)

    截至2026年第一季度最新总资产3747725.75万元,负债2287647.71万元。

利润表
报告期2026-03-312025-12-312025-09-302025-06-30
营业总收入8,188,780,055.6935,361,621,734.9525,894,435,068.4717,075,860,112.16
营业总成本7,879,789,178.2434,112,387,650.6524,983,221,781.216,438,279,511.82
其他经营收益
营业利润312,740,001.631,022,988,204.38823,762,646.19524,870,248.86
利润总额314,307,790.51999,294,796.62822,447,705.46520,722,428.39
净利润237,139,518.53674,635,843.84588,710,745.06375,327,120.46
每股收益
其他综合收益-1,525,891.19-8,387,833.07613,986.042,628,805.36
综合收益总额235,613,627.34666,248,010.77589,324,731.1377,955,925.82
资产负债表
报告期2026-03-312025-12-312025-09-302025-06-30
流动资产:
流动资产合计28,279,869,560.6828,079,061,522.7628,050,937,670.5327,822,270,967.06
非流动资产:
非流动资产合计9,197,387,971.618,791,908,285.018,936,647,655.788,889,673,571.33
资产总计37,477,257,532.2936,870,969,807.7736,987,585,326.3136,711,944,538.39
流动负债:
流动负债合计19,873,929,214.3419,725,513,963.719,648,179,014.119,653,490,408.12
非流动负债:
非流动负债合计3,002,547,891.922,781,857,172.813,048,501,112.72,930,488,687.73
负债合计22,876,477,106.2622,507,371,136.5122,696,680,126.822,583,979,095.85
所有者权益(或股东权益):
归属于母公司股东权益合计12,018,004,410.4111,835,948,719.7111,852,956,503.4711,723,575,812.91
股东权益合计14,600,780,426.0314,363,598,671.2614,290,905,199.5114,127,965,442.54
负债和股东权益合计37,477,257,532.2936,870,969,807.7736,987,585,326.3136,711,944,538.39
现金流量表
报告期2026-03-312025-12-312025-09-302025-06-30
经营活动产生的现金流量:
经营活动现金流入小计7,369,571,599.3637,405,266,841.2526,276,960,397.4317,344,751,244.35
经营活动现金流出小计8,790,891,698.6535,979,387,562.2326,589,498,198.4417,890,884,215.88
经营活动产生的现金流量净额-1,421,320,099.291,425,879,279.02-312,537,801.01-546,132,971.53
投资活动产生的现金流量:
投资活动现金流入小计15,386,96640,349,363.1827,940,922.3927,549,739.82
投资活动现金流出小计410,952,589.83339,956,644.42213,772,988.8129,115,639.68
投资活动产生的现金流量净额-395,565,623.83-299,607,281.24-185,832,066.41-101,565,899.86
筹资活动产生的现金流量:
筹资活动现金流入小计1,255,193,949.956,504,330,076.463,427,503,979.322,300,104,191.34
筹资活动现金流出小计1,174,008,392.738,108,643,218.954,543,313,803.723,025,074,766.63
筹资活动产生的现金流量净额81,185,557.22-1,604,313,142.49-1,115,809,824.4-724,970,575.29
汇率变动对现金及现金等价物的影响-110,384.4-12,441,591-4,976,557.26-1,024,669.09
现金及现金等价物净增加额-1,735,810,550.3-490,482,735.71-1,619,156,249.08-1,373,694,115.77
期末现金及现金等价物余额1,614,075,157.373,349,885,707.672,237,993,441.392,483,455,574.7
补充资料:
现金及现金等价物的净增加额--490,482,735.71--1,373,694,115.77
TOP↑